Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), a common but overlooked virus that poses serious risks to vulnerable populations, including people with compromised immune systems. According to the Centers for Disease Control and Prevention, the virus is the most infectious cause of birth defects in the United States.